- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2017
- Public Summary Document (PSD) March 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2017 PBAC Meeting - Word
Goserelin – March 2017
Goserelin: 3.6 mg implant; Zoladex Implant®
Last updated
14 July 2017